Clinical Trials for Ulcerative Colitis

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

NCT ID: NCT06880744

This clinical trial is looking at how well a medication called risankizumab works compared to another medication called vedolizumab in treating adults with moderate to severe ulcerative colitis (UC...

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

NCT ID: NCT06636656

This clinical trial is studying a new treatment called BI 3032950 to see if it can help people with ulcerative colitis, a condition that causes inflammation in the digestive tract. Adults aged 18 t...

Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease

NCT ID: NCT06510296

This clinical trial is looking at a new digital program designed to help Black and Hispanic patients who have inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. The go...

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06290934

This clinical trial is studying a new treatment called GS-1427 for people with moderately to severely active ulcerative colitis, a condition that causes inflammation in the digestive tract. The mai...

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

NCT ID: NCT06975722

This clinical trial is looking at a new treatment called SAR442970 for adults with moderate to severe Ulcerative Colitis, a condition that causes inflammation in the colon. The goal is to find out ...

Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

NCT ID: NCT06560021

This clinical trial is looking at two different methods of performing colonoscopy in patients with inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. Specifically, t...

Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis

NCT ID: NCT07114159

This clinical trial is studying a treatment called sacral nerve stimulation to see if it is safe and helpful for people with ulcerative colitis, a condition that causes inflammation and sores in th...

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

NCT ID: NCT05782907

This clinical trial is studying a medication called Upadacitinib (also known as RINVOQ) to see how safe and effective it is for children and teenagers with moderately to severely active ulcerative ...

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT ID: NCT06979336

This clinical trial is investigating a new treatment called RO7837195 for people with moderately to severely active ulcerative colitis (UC), a condition that causes inflammation in the digestive tr...

Immune Regulation in Ulcerative Colitis or Crohn s Disease

NCT ID: NCT00001184

This clinical trial is looking into how the immune system manages inflammation in patients with Crohn's disease and ulcerative colitis, which are types of inflammatory bowel disease. Researchers wa...

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT ID: NCT06052059

This clinical trial is studying a new medication called tulisokibart (MK-7240) to see if it is effective and safe for people with moderately to severely active ulcerative colitis, a condition that ...

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

NCT ID: NCT06095128

This clinical trial is studying the combined effect of two medications, vedolizumab and tofacitinib, in adults with moderate to severe ulcerative colitis (UC). The goal is to see how well this comb...

MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease

NCT ID: NCT06788340

This clinical trial is looking at how to best manage dosages of two medications, Ustekinumab (UST) and Vedolizumab (VDZ), for adults with Inflammatory Bowel Disease (IBD), which includes conditions...

PIBD-SETQuality: the Inception Cohort and Safety Registry

NCT ID: NCT03571373

The PIBD-SETQuality trial is studying how effective and safe current treatments are for children and teenagers with inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis...

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

NCT ID: NCT03816345

This clinical trial is studying how well a medication called nivolumab works for patients who have autoimmune disorders and advanced cancers that are difficult to treat or remove with surgery. Nivo...

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

NCT ID: NCT06581328

This clinical trial is studying a medication called Vedolizumab to see how effective it is for adults with Ulcerative Colitis (UC) or Crohn's Disease (CD), which are long-term conditions affecting ...

Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)

NCT ID: NCT07095634

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

NCT ID: NCT07012395

This clinical trial is studying new treatments for adults with moderate to severe ulcerative colitis (UC), a condition that causes ongoing inflammation in the digestive tract. The main goal is to e...

A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

NCT ID: NCT07083193

This clinical trial is testing a new medicine called AC-101 to see if it is safe and helpful for people with moderate to severe ulcerative colitis, which is a condition that causes inflammation and...

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

NCT ID: NCT04844606

The AMAZ trial is a clinical study looking at the long-term effects of a medication called mirikizumab in children and teenagers with ulcerative colitis (UC) or Crohn's disease (CD). This study is ...